Tobacco Free Ireland

Objectives

Tobacco Free Ireland aims to achieve a tobacco-free society by 2025, defined as smoking prevalence below 5% of the population. It frames tobacco use as a major, preventable cause of mortality, illness, health inequalities and exposure to second-hand smoke, requiring sustained and comprehensive action across the population.[1][2][3]The strategy builds on Ireland’s earlier tobacco-control policy and aligns with Healthy Ireland, the World Health Organization Framework Convention on Tobacco Control, European Union legislation and the MPOWER model.[4][2][5][6]

• Reduce smoking initiation, particularly among children and young people, through prevention, restrictions on access and tobacco-free settings.[7][8]
• Reduce smoking prevalence and relapse by making cessation advice, treatment and behavioural support available across community, primary and secondary care.[9][10]
• Protect non-smokers, especially children, from second-hand smoke through smoke-free environments, strengthened legislation and effective enforcement.[2][11]
• Denormalise tobacco use through public education, health warnings, standardised packaging, advertising restrictions and reduced exposure to smoking imagery and promotion.[12][13][14]
• Regulate tobacco products, retailing and marketing, including retailer licensing, sales restrictions, ingredient reporting, product warnings and controls on emerging promotional practices.[15][16]
• Use taxation and pricing measures to reduce consumption, encourage quitting and prevent youth initiation, while addressing illicit trade.[14][17]
• Target action towards groups experiencing greater tobacco-related risk or inequality, including young people, lower-income smokers, young women, pregnant and post-partum women, and people with cardiac or respiratory disorders.[18][7][10]

Implementation

The policy adopts a multi-faceted, evidence-based approach that combines population-wide regulation and communications with targeted interventions for higher-risk groups.[19][7]Delivery is intended to be coordinated across government, health services, enforcement agencies, civil society, professional bodies and international partners, with a detailed action plan to assign responsibilities and phased implementation timeframes.[4][20][21]

• Coordinate national implementation through the Department of Health, Health Service Executive, National Tobacco Control Office, Office of the Revenue Commissioners, other government departments and state agencies.[1][4]
• Use the Health Service Executive Tobacco Control Framework and its National Implementation Group to progress the identified actions, supported by a Tobacco Control Stakeholder Network representing non-governmental and professional organisations.[22]
• Expand tobacco-free environments across healthcare sites, schools, childcare facilities, third-level institutions, government and sporting facilities, playgrounds, parks and beaches, working with local authorities and relevant stakeholders.[23]
• Enforce smoke-free and sales-to-minors legislation through the Health Service Executive Environmental Health Service, the National Tobacco Control Inspection Programme, public-complaint responses, routine and targeted inspections, test-purchase activity, fixed penalties and court action where required.[24][15][11]
• Develop retail controls through registration and licensing, restrictions on sales locations and mobile units, prohibitions on self-service vending machines, sanctions for convicted retailers and use of the Retail Register to support compliance.[15]
• Deliver cessation support through general practitioners, nurses, hospital clinicians, pharmacists, dentists, trained cessation specialists, primary-care services and the National Smokers’ QUITline.[9][25]
• Strengthen cessation provision by appointing a national lead, developing national guidelines and minimum service standards, training frontline healthcare workers, establishing a national service database and tailoring provision to local needs and disadvantaged communities.[25][10]
• Use sustained social marketing, mass-media campaigns, telephone and online support, public relations, counselling and school-based prevention education to increase awareness, encourage quitting and prevent initiation.[13][26]
• Implement combined text and pictorial health warnings, pursue standardised packaging, maintain advertising, sponsorship, promotion and point-of-sale display restrictions, and monitor brand stretching and new marketing practices.[13][26][14]
• Increase tobacco excise duties, including on roll-your-own products, and coordinate intelligence-led action against illicit trade involving Revenue, An Garda Síochána, European Union bodies and international counterparts.[4][17]
• Collaborate with European Union partners on product regulation and the Tobacco Products Directive, implement the Framework Convention on Tobacco Control and its illicit-trade protocol, and share experience with Northern Ireland through North/South cooperation.[4][20][16][21]
• Monitor prevalence, exposure, compliance, service coverage, treatment outcomes, supply and demand, marketing activity and policy effectiveness through regular surveys, research, inspections and a Performance Indicator Framework.[27][10]
• Evaluate campaigns, smoke-free initiatives, prevention programmes and legislative measures continuously, using findings to identify intervention needs and inform policy development.[12][28][27]
• Deliver measures within existing resources while considering a tobacco-industry levy, an environmental levy, increased investment in quit campaigns and removal of value-added tax from nicotine-replacement therapy; no quantified overall implementation budget is specified.[4][10]

Monitoring & Evaluation

Tobacco Free Ireland uses smoking prevalence, tobacco-use surveillance, compliance monitoring, research and programme evaluation to track progress towards a tobacco-free society, defined as smoking prevalence below 5% by 2025.[1][2]The framework combines population surveys, enforcement data, service information and international evidence, but several sections do not specify a single consolidated national reporting timetable or full accountability framework.[27][21]

• Monitor smoking prevalence through the Survey of Lifestyle, Attitudes and Nutrition, Health Service Executive and National Tobacco Control Office surveys, Eurobarometer, the Health Behaviour in School-aged Children survey, and monthly quota surveys undertaken by Ipsos MRBI.[29][27]
• Track reported prevalence trends, including adult smoking prevalence declining from 29% in 2007 to 22% in 2012, and current smoking among 10 to 17 year olds declining from 21.2% in 1998 to 12% in 2010.[1][30]
• Measure inequalities and risk patterns by gender, age, social class and region, with attention to children, young people, young women and lower socioeconomic groups.[29][18]
• Establish regular, reliable collation of smoking-prevalence data and ongoing research on tobacco supply and demand, prevention, cessation, second-hand-smoke exposure and tobacco-industry marketing.[28][27]
• Use a Performance Indicator Framework to assess prevention-policy effectiveness continuously and develop indicators showing whether tobacco-control policies are effective.[27]
• Evaluate tobacco-control interventions, including smoke-free-environment initiatives, campaigns, cessation programmes, voluntary measures and local-authority by-laws, to determine effectiveness and whether further legislation is needed.[12][28][23]
• Monitor legislative compliance through the National Tobacco Control Inspection Programme, public complaints, routine and targeted inspections, enforcement cases and test-purchase programmes.[24]More than 300 public complaints were received annually by the National Tobacco Control Office, and more than 200 cases concerning breaches of sales-to-minors provisions had been taken since 2004.[24]
• Assess compliance with specific measures, including reported 97% compliance with smoke-free workplace legislation and point-of-sale display restrictions, while monitoring exemptions, retail sales to minors, product warnings and emerging marketing practices.[31][28]
• Measure cessation and communication activity through service utilisation, QUITline volumes, service coverage, provider skills and outcomes; the proposed national cessation-service database is intended to address incomplete information on provision and results.[25][10]
• Maintain international accountability through World Health Organization Framework Convention on Tobacco Control implementation reviews by the Conference of the Parties, held at two-year intervals.[16]The future national action plan is intended to allocate responsibilities and implementation timeframes, although national indicators, reporting arrangements and evaluation methods are not fully specified in the supplied text.[21]

Costing & Financing

The policy identifies tobacco as a substantial health-system and economic burden, while proposing implementation largely within existing resources and using taxation, possible levies and cessation investment as potential financing mechanisms.[4][3]No overall implementation budget, quantified funding gap, expenditure allocation or resource-mobilisation target is specified.[4][2]

• Recognise direct Irish health expenditure on smoking-related disease of approximately 500 million euro in 2009, alongside reported productivity and long-term-incapacity losses exceeding 160 million euro and premature-mortality costs exceeding 3,500 million euro.[3]
• Record tobacco excise-duty revenue of 1,216.5 million euro in 2009 and 1,072 million euro in 2012.[3]
• Apply annual tobacco excise-duty increases over five years, increase duties on roll-your-own and other tobacco products, and continue action against illicit trade.[4]Excise duty on a 20-cigarette pack increased by 25 euro cent in 2012 and 10 euro cent in 2013.[17]
• Consider a tobacco-industry levy or similar ring-fenced mechanism for health promotion, tobacco control and action against illegal tobacco trade, as well as an environmental levy linked to waste policy and producer responsibility.[4]
• Fund cessation support through free General Medical Services prescriptions for nicotine replacement therapy, bupropion and varenicline, and subsidies for bupropion and varenicline under the Drugs Payment Scheme for eligible people without medical cards.[10]
• Increase investment in mass-media quit campaigns and consider removing value-added tax from nicotine replacement therapy, without quantified fiscal or budgetary implications.[10]
• Note that smoking cessation is characterised as highly cost-effective: a United Kingdom appraisal estimated costs per life year gained at £210 to £870.[9]
• Charge a once-off 50 euro Retail Register applicant fee; the ongoing maintenance cost is not quantified.[15]
• Recognise that higher tobacco taxes and prices are expected to reduce consumption and initiation while increasing revenues, although the source notes illicit-trade and inflation considerations.[14][20]